Page no.
Practical:
Quantity taken
9g
3g
1.8g
0.3g
0.9g
3ml
60ml
Role of Ingredient
API, Protective agent
Astringent
Suspending agent
Viscosity enhancer
Preservative
Humectant
Vehicle
Marketed formulation:
Calamine suspension(Zincal):
Company Name: Alive Manufacturer
Content: Calamine IP150 gm
Zinc oxide IP50 gm
Bentonite IP30 gm
Glycerin IP50 ml
Sodium citrate IP- 5 gm
Liquid phenol IP- 5 ml
Purified water q.s.-100 ml
Volume: 100 ml
Procedure:
Dissolve Sodium citrate with 1/4th quantity of water.
Mix Calamine, Zinc oxide & Bentonite with Sodium citrate solution.
Dilute above mixture with some quantity of water.
Date:
Page no.
Observation
1. Sedimentation Volume Ratio(SVR)
Suspension
Calamine
lotion
Time
(min)
Initial
Height
(H0)
Ultimate
Height(Hu)
SVR
LF
LF
LF
MF
MF
0
10
20
30
40
50
60
MEAN(d)
NO. OF
PARTICLES(f)
f*d
Average
SVR
MF LF
MF
Date:
Add Liquid phenol & Glycerin to above mixture and mix well.
Adjust final volume with water.
Evaluation parameters:
1.
2.
3.
4.
5.
6.
Page no.
Date:
Page no.
3. Density:
A. Calamine lotion of LF:
Initial weight of empty bottle W0 =
Bottle + suspension W1 =
Bottle capacity = 10 ml
Density = W1-W0
10
5. Viscosity
Result:
PARAMETER LF
SVR
Particle size
distribution
pH value
Density
Redispersibility
Viscosity
MF
Date:
Page no.
Comment:
1. Topical suspension having high amount of solids should have minimum
sedimentation throughout the shelf-life.
2. In present study, attempt is made to prepare efficient stable suspension of
high amount of solid and compare with marketed formulation we
conclude from observed parameters that marketed formulation were
found to be more stable and efficient.
3.
Reference:
1. Pharmaceutical Dosage Form: Disperse system, Leon Lachman, Herbert
Lieberman, volume 2.